Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 2089, March 1, 2007. doi: 10.1158/0008-5472.CAN-06-3625
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.-L.
Right arrow Articles by Chen, J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-L.
Right arrow Articles by Chen, J.-Y.

Cell, Tumor, and Stem Cell Biology

Osteopontin Promotes Integrin Activation through Outside-In and Inside-Out Mechanisms: OPN-CD44V Interaction Enhances Survival in Gastrointestinal Cancer Cells

Jia-Lin Lee1, Mei-Jung Wang1, Putty-Reddy Sudhir1, Gen-Der Chen1,2, Chin-Wen Chi3,5 and Jeou-Yuan Chen1,4

1 Institute of Biomedical Sciences, Academia Sinica; Institutes of 2 Biochemistry, 3 Pharmacology, and 4 Genome Sciences, National Yang-Ming University; 5 Department of Medical Research and Education, Veterans General Hospital, Taipei, Taiwan, Republic of China

Requests for reprints: Jeou-Yuan Chen, Institute of Biomedical Sciences, Academia Sinica, 128 Section 2 Academia Road, Taipei 11529, Taiwan, Republic of China. Phone: 886-2-27899046; Fax: 886-2-27858594; E-mail: bmchen{at}ibms.sinica.edu.tw.

Osteopontin (OPN) and splice variants of CD44 (CD44V) have independently been identified as markers for tumor progression. In this study, we show that both OPN and CD44V are frequently overexpressed in human gastric cancer and that OPN-engaged CD44V ligation confers cells an increased survival mediated through integrin activation. First, we show that OPN treatment confers cells an increased resistance to UV-induced apoptosis. The OPN-mediated antiapoptosis is dependent on the expression of the variant exon 6 (V6)- or V7-containing CD44 as shown by overexpression of individual CD44V in gastric AZ521 cells that express no or very low level of endogenous CD44 and by knockdown of the constitutively expressed V6-containing CD44 isoforms in colon HT29 cells. Although OPN also interacts with RGD integrins, OPN-RGD sequence is dispensable for OPN-mediated antiapoptosis. OPN-induced antiapoptosis is mainly attributed to the engagement of CD44V isoforms and the relay of an inside-out signaling via Src activity, leading to robust integrin activation. Furthermore, OPN-elicited antiapoptosis was observed when cells were plated on fibronectin but not on poly-D-lysin, and preincubation of cells with anti-integrin ß1 antibody to block integrin-extracellular matrix (ECM) interaction or ectopic expression of the dominant-negative forms of focal adhesion kinase to block ECM-derived signal abolished OPN-induced survival, suggesting that OPN-elicited antiapoptotic function is propagated from matrix transduced by integrin. Taken together, we showed that OPN-CD44V interaction promotes ECM-derived survival signal mediated through integrin activation, which may play an important role in the pathogenic development and progression of gastric cancer. [Cancer Res 2007;67(5):2089–97]




This article has been cited by other articles:


Home page
JCBHome page
J.-L. Lee, M.-J. Wang, and J.-Y. Chen
Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
J. Cell Biol., June 15, 2009; 185(6): 949 - 957.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
P. Klingbeil, R. Marhaba, T. Jung, R. Kirmse, T. Ludwig, and M. Zoller
CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance
Mol. Cancer Res., February 1, 2009; 7(2): 168 - 179.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. Song, Y. Ming, Y. Mao, S. Bao, and G. Ouyang
Osteopontin Prevents Curcumin-Induced Apoptosis and Promotes Survival Through Akt Activation via {alpha}v{beta}3 Integrins in Human Gastric Cancer Cells
Experimental Biology and Medicine, December 1, 2008; 233(12): 1537 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-L. Lee, M.-J. Wang, P.-R. Sudhir, and J.-Y. Chen
CD44 Engagement Promotes Matrix-Derived Survival through the CD44-SRC-Integrin Axis in Lipid Rafts
Mol. Cell. Biol., September 15, 2008; 28(18): 5710 - 5723.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Vachon, R. Martin, V. Kwok, V. Cherepanov, C.-W. Chow, C. M. Doerschuk, J. Plumb, S. Grinstein, and G. P. Downey
CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages
Blood, December 15, 2007; 110(13): 4492 - 4502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.